Brigit Biofarmaka Teknologi Tbk. vs Soraya Berjaya Indonesia Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp252 (market cap 172.82B, 218.7K 24h volume), while Soraya Berjaya Indonesia Tbk. trades at Rp82 (market cap 65.6B, 377.6K 24h volume). The key difference: Brigit Biofarmaka Teknologi Tbk. is far larger — about 2.6× Soraya Berjaya Indonesia Tbk.'s market cap, and Soraya Berjaya Indonesia Tbk. is more actively traded (377.6K versus 218.7K). Which is the better fit depends on your goals.
| OBAT | SPRE | |
|---|---|---|
Market Cap | 172.82B | 65.6B |
Volume | 218.7K | 377.6K |
Lot | 2.19K | 3.78K |
Turnover | 53.51M | 31.09M |
Average Price | 244.66 | 82.33 |
Value | 53.51M | 31.09M |
Indicative Equilibrium Price | 252 | 82 |
Indicative Equilibrium Volume | 48 | 2 |
Trailing returns across standard periods
Latest headlines on both assets
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →PT. Soraya Berjaya Indonesia (Company) was established based on Deed No. 05 dated March 05, 2015 by Notary Martalena, S.H., in Padang. Perseroan memulai kegiatan komersilnya pada tahun 2015. dengan mengoperasikan menggunakan merek dagang Soraya Bed Sheet.
Read more on SPRE →